Traditional Member $7.50 | Retail: $10Approved for 0.50 A CE Credit
This article
reviews the use of PET imaging for patients with breast cancer, highlighting
the clinical indications and limitations of FDG PET/CT, the potential use of
PET/MRI, and FES, a newly approved radiopharmaceutical for estrogen receptor
imaging.
The Clinics are scholarly articles licensed from Elsevier to provide additional technical content for ASRT members.
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same biennium.
Free access is included with membership. All titles for which you have not previously earned CE credit appear in your CE library.
Not a member? Call Member Services to join 800-444-2778.